[DRUG] YoY Quarter Result on 30-Sep-2022 [#Q4]

Stock
[DRUG] Bright Minds Biosciences Inc.
Announcement Date
29-Dec-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q4]
Profit Trend
QoQ- -9.10%
YoY- -1.15%
Quarter Report
DRUG's Result
DRUG's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 0 0 0 0 -
PBT -1,528 -2,961 -2,867 -403 55.93%
Tax -58 -61 -3,053 -397 -47.33%
NP -1,528 -2,900 -2,867 -403 55.93%
Tax Rate - - - - -
Total Cost 1,528 2,900 2,867 403 55.93%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.41 -1.05 -1.21 -0.96 -24.69%
EPS Diluted -0.41 -1.05 -1.21 -0.96 -24.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.